Skip to main content

Table 4 Description of infants with possibly severe symptoms and/or high lithium levels

From: High lithium concentration at delivery is a potential risk factor for adverse outcomes in breastfed infants: a retrospective cohort study

ID, (HEG/ LEG)

Lithium concentration (meq/l)

Breastfeeding

Infant symptoms

Other psychotropic drugs

Potential cause of pathology

MS

UC

IS

FU

MS-FU

At birth

At follow-up

At birth

At follow-up

A (HEG)

0.8

0.9

0.6

0.7

0.6

Part

Part

Mild prematurity, large for gestational age, need for CPAP for one day. Initial weight loss of 15%

Poor weight gain at 11 days of age, recommended to increase formula

SSRI, anxiolytics

Combination of exposure to lithium and other drugs, lower kidney function due to prematurity and dehydration due to large initial weight loss

B (HEG)

0.8

0.9

0.7

1.2

Part

Part

Found cyanotic in the bed at maternity ward at 2 days of age but recovered without respiratory support. Observed for 2 days at NICU

No clinical symptoms but advised to stop breastfeeding due to high lithium concentration at 29 days of age

Anxiolytics when needed

Combination of pre- and postnatal exposure together with some unknown inborn fragility in the infant causing both the cyanotic spell and the high lithium concentration at follow-up?

C (HEG)

1.5

1.0

1.0

0.2

0.7

Excl

Excl

Jittery at birth, blood glucose checked, normal. Elevated plasma creatinine level of 84 μmol/l at 48 h of age

Normalized plasma creatinine, 48 μmol/l, but jaundiced, tired and poor weight gain at 9 days of age

SSRI, central stimulants, anxiolytics

Toxic maternal serum lithium concentration and potentially maternal dehydration causing increased infant creatinine level at birth. However, the effects at follow-up might rather have been caused by the polypharmacy

D (HEG)

0.9

1.2

0.1

Excl

Excl

No clinical symptoms at birth

No clinical symptoms at 26 days of age

Antipsychotics

High infant serum concentration at birth caused by high intrauterine exposure, without any clinical consequences and good clearance at follow-up

E  (LEG)

0.5

0.5

0.4

 < 0.05

0.6

Excl

Part

Jittery at birth, blood glucose checked × 3, normal

Tired with poor weight gain at 19 days of age, recommended to introduce formula

Anxiolytics

Jitteriness and poor weight gain may have been caused by the intrauterine lithium exposure as well as the polypharmacy

F  (LEG)

0.4

0.3

0.4

0.1

0.5

Part

Part

Cyanotic with respiratory distress at 25 min of age. Admitted to NICU, treated with CPAP for 1 day. Elevated thyroid hormone level, 47 pmol/l

Poor weight gain at 12 days of age. Normalized thyroid levels

SSRI, antipsychotics

Both the need for respiratory support at birth and the poor weight gain may be effects of polypharmacy rather than lithium exposure only

G (LEG)

0.2

0.2

 < 0.05

0.1

Part

Part

Need for CPAP briefly from one minute of age, no need for admission to NICU

No symptoms at the follow-up at eight days of age

Central stimulants

Need for respiratory support initially likely to be related to the instrumental delivery rather than exposure to low dose lithium

H (LEG)

0.2

0.2

0.1

Excl

Excl

Pale and hypotonic shortly after birth. Receives treatment with CPAP briefly, after that no need for admission to NICU

No symptoms at the follow-up at 29 days of age

Short need for respiratory support due to other factors than the low exposure to lithium

  1. HEG: High exposure group, serum lithium measured at birth ≥ 0.6 meq/l, LEG: Low exposure group, serum lithium measured at birth < 0.6 meq/l. MS: Maternal serum at delivery, UC: Umbilical cord, IS: Infant Serum at 2 days of age, FU: Infant serum at follow-up, MS-FU: Maternal serum at follow-up CPAP: Continuous positive airway pressure, NICU: Neonatal intensive care unit, Excl: Exclusive, Part: Partially, SSRI: selective serotonin reuptake inhibitors, anxiolytics: benzodiazepines, antihistamines and other anxiolytic and sedative drugs